2687-0940Challenges in modern medicine2687-094010.18413/2687-0940-2020-43-1-38-459INTERNAL DISEASESCLINICAL AND PATHOGENETIC 3 APPLICATION OF THE HSP70 HEAT SHOCK PROTEIN IN MYOCARDIAL INFARCTION ON THE BACKGROUND OF CHRONIC OBSTRUCTIVE LUNG DISEASECLINICAL AND PATHOGENETIC 3 APPLICATION OF THE HSP70 HEAT SHOCK PROTEIN IN MYOCARDIAL INFARCTION ON THE BACKGROUND OF CHRONIC OBSTRUCTIVE LUNG DISEASENaumovA. V.NaumovA. V.ProkofievаT. V.ProkofievаT. V.prokofeva-73@inbox.ruPoluninaO. S.PoluninaO. S.SaroyantsL. V.SaroyantsL. V.202043100

In order to assess the clinical and pathogenetic value of the heat shock protein HSР 70 in patients with myocardial infarction (MI) on the background of chronic obstructive pulmonary disease (COPD), 65 patients were examined: 28 MI patients and 37 MI patients with COPD, as well as 20 somatically healthy individuals. ELISA determined the level of HSP70. The highest level of HSP70 was found in MI patients with COPD, especially in the early stages of hospitalization. The obtained data on the relationship of HSP70 with the depth of myocardial lesion suggest the possibility of using this heat shock protein not only as a marker of early diagnosis of MI in patients with COPD, but also as a marker of the severity of MI in comorbid patients with COPD. This will facilitate early detection of coronary events in patients with COPD, which is especially important given the high frequency of erased forms of MI and atypical symptoms of MI in patients with COPD.

In order to assess the clinical and pathogenetic value of the heat shock protein HSР 70 in patients with myocardial infarction (MI) on the background of chronic obstructive pulmonary disease (COPD), 65 patients were examined: 28 MI patients and 37 MI patients with COPD, as well as 20 somatically healthy individuals. ELISA determined the level of HSP70. The highest level of HSP70 was found in MI patients with COPD, especially in the early stages of hospitalization. The obtained data on the relationship of HSP70 with the depth of myocardial lesion suggest the possibility of using this heat shock protein not only as a marker of early diagnosis of MI in patients with COPD, but also as a marker of the severity of MI in comorbid patients with COPD. This will facilitate early detection of coronary events in patients with COPD, which is especially important given the high frequency of erased forms of MI and atypical symptoms of MI in patients with COPD.

heat shock proteinsHSP70myocardial infarctionchronic obstructive pulmonary diseasecomorbidityheat shock proteinsHSP70myocardial infarctionchronic obstructive pulmonary diseasecomorbidityСписок литературы1. Pokazateli immunnogo statusa pri khronicheskoy obstruktivnoy bolezni legkikh [Indicators of the immune status in chronic obstructive pulmonary disease]. Uspekhi sovremennogo estestvoznaniya. 9: 195–197.2. Ivanova N.M., Tsybikov N.N., Sormolotova I.N., Tsybikov N.B., Ivanov M.O. 2019. Shaperony kak svyazuyushchee zveno mezhdu atopicheskim dermatitom i allergicheskim rinitom [Chaperones as a link between atopic dermatitis and allergic rhinitis]. Meditsinskiy vestnik Severnogo Kavkaza. 14 (2): 349–351.3. Kabalyk M.A. 2019. Kliniko-patogeneticheskoe znachenie belkov teplovogo shoka s massoy 70 i 27 kDv pri osteoartrite [Clinical and pathogenetic value of heat shock proteins with a mass of 70 and 27 KdV in osteoarthritis]. Nauchno-prakticheskaya revmatologiya. 55 (2): 187–191.4. Kuz'michev B.Yu., Polunina E.A., Kuz'michev K.Yu., Lipnitskaya E.A., Adzhyan M.S. 2017. Issledovanie urovnya gomotsisteina u patsintov s infarktom miokarda na fone khronicheskoy ob-struktivnoy bolezni legkikh [Study of the level of homocysteine in patients with myocardial infarction against the background of chronic obstructive pulmonary disease]. Astrakhanskiy meditsinskiy zhurnal. 12 (4): 44–50.5. Naumov A.V., Saroyants L.V., Prokof'eva T.V., Polunina O.S., Polunina E.A. 2019. In-formativnost' tsitokinovogo profilya v prognozirovanii oslozhneniy u bol'nykh infarktom miokarda na fone khronicheskoy obstruktivnoy bolezni legkikh [Informative cytokine profile in predicting complica-tions in patients with myocardial infarction against the background of chronic obstructive pulmonary dis-ease]. Meditsinskiy alfavit. 22 (397): 33–36.6. Polikutina O.M., Slepynina Yu.S., Bazdyrev E.D., Karetnikova V.N., Barbarash O.L. 2014. Iskhody infarkta miokarda s pod"emom segmenta ST u patsientov s khronicheskoy obstruktivnoy bolezn'yu legkikh v Kemerovskoy oblasti [Outcomes of SТ-segment elevation myocardial infarction in patients with chronic obstructive pulmonary disease in the Kemerovo region]. Rossiyskiy Kardiolog-icheskiy Zhurnal. 7 (111): 91–97.7. Bielecka-Dabrowa A., Barylski M., Mikhailidis D.P., Rysz J., Banach M. 2009. HSP 70 and atherosclerosis protector – or activator? Expert Opinion on Therapeutic Targets. 13: 307–317.8. Calderwood S.K., Gong J. Murshid A. 2016. Extracellular HSPs: The Complicated Roles of Extracellular HSPs in Immunity. Front. Immunol. 7: 159.9. Donaldson G.C., Hurst J.R., Smith C.J., Hubbard R.B., Wedzicha J.A. 2010. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest. 137: 1091–1097.10. Dybdahl B., Slørdahl S.A., Waage A., Kierulf P., Espevik T., Sundan A. 2005. Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart. 91: 299–304.11. Eapen D.J., Ghasemzadeh N., MacNamara J.P., Quyyumi A. 2014. The Evaluation of Novel Biomarkers and the Multiple Biomarker Approach in the Prediction of Cardiovascular Disease. Curr. Cardiovasc. Risk. Rep. 8: 408.12. Guisasola M.C., Ortiz A., Chana F., Alonso B. Vaquero J. 2015. Early inflammatory re-sponse in polytraumatized patients: Cytokines and heat shock proteins. A pilot study. Orthop. Traumatol. Surg. Res. 101: 607–611.13. Haider Th., Simader E., Glück O., Ankersmit H.J., Heinz Th., Hajdu S., Negrin L.L. 2019. Systemic release of heat-shock protein 27 and 70 following severe trauma. Scientific Reports. 9: 9595.14. Kirsty M. Danielson1 and Saumya 2014. Das Extracellular Vesicles in Heart Disease: Ex-citement for the Future Exosomes Microvesicles. 2: 1. doi: 10.577215. Lichtenauer M., Zimmermann M., Nickl S., Lauten A., Goebel B., Pistulli R., Yilmaz A., Figulla H.R., Ankersmit H.J., Jung C. 2014. Transient hypoxia leads to increased serum levels of heat shock protein-27, -70 and caspase-cleaved cytokeratin 18. Clin. Lab. 6: 323–328.16. Roversi S., Fabbri L.M., Sin D.D., Hawkins N.M., Agustí A. Chronic obstructive pulmonary disease and cardiac diseases. 2016. An urgent need for integrated care. Am. J. Respir. Crit. Care. Med. 194: 1319–1336.17. Roversi S., Roversi P., Spadafora G., Rossi R., Fabbri L.M. 2014. Coronary artery disease concomitant with chronic obstructive pulmonary disease. Eur. J. Clin. Invest. 44: 93–102.18. Saban K.L., Hoppensteadt D., Bryant F.B., Devon H.A. 2013. Social determinants and heat shock protein-70 among african american and non-hispanic white women with atherosclerosis: a pilot study. Biol Res Nurs. 16(3): 258–265.19. Trinkmann F., Saur J., Borggrefe M. and Ibrahim Aki J. 2019. Cardiovascular Comorbidities in Chronic Obstructive Pulmonary Disease (COPD) – Current Considerations for Clinical Practice Clin. Med. 8(1): 69.20. Westerik J.A., Metting E.I.,van Boven J.F., Tiersma W., Kocks J.W., Schermer T.R. 2017. Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD. Respir. Res. 18: 31.21. Zhang X., Xu Z., Zhou L., Chen Y., He M., Cheng L., Hu F.B., Tanguay R.M., Wu T. (2010) Plasma levels of Hsp70 and anti-Hsp70 antibody predict risk of acute coronary syndrome. Cell Stress Chaperones 15: 675–686.